LEADER 01473nam--2200397---450- 001 990002078610203316 005 20091119113205.0 010 $a88-14-10234-1 035 $a000207861 035 $aUSA01000207861 035 $a(ALEPH)000207861USA01 035 $a000207861 100 $a20041013d2003----km-y0enga50------ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $a<> disciplina della subfornitura nelle attività produttive$ecommento alla legge 18 giugno 1998, n. 192 come modificata dalla legge 5 marzo 2001, n. 57 e dal decreto legislativo 9 ottobre 2002, n. 231$fCarlo Berti, Barbara Grazzini 210 $aMilano$cA. Giuffrè$d2003 215 $aVIII, 247 p.$d24 cm 225 2 $aResponsabilità, comunicazione, impresa$v10 410 0$12001$aResponsabilità, comunicazione, impresa$v10 606 0 $aSubcontratto di fornitura 676 $a346.45024 700 1$aBERTI,$bCarlo$03718 701 1$aGRAZZINI,$bBarbara$0279566 801 0$aIT$bsalbc$gISBD 912 $a990002078610203316 951 $aXXX.B. Coll. 5/ 9 (COLL PVI 10)$b42515 G.$cXXX.B. Coll. 5/ 9 (COLL PVI)$d00136057 959 $aBK 969 $aGIU 979 $aACQUISTI$b10$c20041013$lUSA01$h1551 979 $aANNASEN$b90$c20050208$lUSA01$h1542 979 $aRSIAV4$b90$c20091119$lUSA01$h0956 979 $aRSIAV4$b90$c20091119$lUSA01$h1132 996 $aDisciplina della subfornitura nelle attività produttive$91041894 997 $aUNISA LEADER 01978nam 22005053u 450 001 9910463165103321 005 20210106202529.0 010 $a1-78084-168-X 035 $a(CKB)2670000000391299 035 $a(EBL)1179660 035 $a(OCoLC)851970669 035 $a(SSID)ssj0001599939 035 $a(PQKBManifestationID)16306723 035 $a(PQKBTitleCode)TC0001599939 035 $a(PQKBWorkID)14892847 035 $a(PQKB)10009020 035 $a(MiAaPQ)EBC1179660 035 $a(Au-PeEL)EBL1179660 035 $a(OCoLC)828119265 035 $a(EXLCZ)992670000000391299 100 $a20131021d2013|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aOsteoporosis$b[electronic resource] 205 $a1st ed. 210 $aLondon $cFuture Medicine Ltd$d2013 215 $a1 online resource (88 p.) 300 $aDescription based upon print version of record. 311 $a1-78084-170-1 327 $aTitle page; Copyright page; Contents; Foreword. Osteoporosis; 1. Pathogenesis of osteoporosis; 2. Diagnosis of osteoporosis; 3. Nonmedical treatment of osteoporosis; 4. Pharmacological treatment of osteoporosis; 5. Preventing postmenopausal osteoporosis; Index 330 $aOsteoporosis is considered to be a major health issue in all developed countries, but recent years have seen improvements in understanding and management of the disorder. This work, authored by a team of international experts, explores the pathogenesis and diagnosis of disease, available treatments (pharmacological and non-medical) together with options for prevention. 608 $aElectronic books. 676 $a616.716 700 $aReginster$b Jean-Yves$01039896 701 $aBruye?re$b Olivier$01039897 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910463165103321 996 $aOsteoporosis$92462368 997 $aUNINA